Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: RexMedical- Option* Vena Cava Filter IDE Study [NA]
Rex Medical's IDE trial evaluating the Option Vena Cava Filter for preventing pulmonary embolism has completed. Results were posted on 2010-…
-
FDA approval · 2010-07-23FDA Approved: ENOXAPARIN SODIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's Original Application for Enoxaparin Sodium, a generic injectable anticoagulant. The approval authorizes marketing …
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid [Phase 4]
Phase 4 clinical trial update evaluating the pharmacodynamic interaction between warfarin and amoxicillin-clavulanic acid and its impact on …
-
FDA approval · 2010-06-30FDA Approved: HEPARIN SODIUM — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for heparin sodium from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Inhaled Nitric Oxide in Pulmonary Embolism [Phase 2]
A Phase 2 trial evaluating inhaled nitric oxide for pulmonary embolism has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Safety Study of Outpatient Treatment for Pulmonary Embolism [Phase 3]
Phase 3 safety study of outpatient treatment for pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Pulmonary Embolism: Multifunctional Assessment of Prognosis
Clinical trial update evaluating multifunctional prognosis assessment in patients with pulmonary embolism.
-
CLINICAL_TRIALS research · 2010-04-20Clinical Trial Update: Factor XIII and Pulmonary Embolism in Neurosurgical Patients
A clinical trial update from Ludwig-Maximilians-Universität Munich exploring the role of Factor XIII in pulmonary embolism among neurosurgic…
-
CLINICAL_TRIALS trial_result · 2010-04-15Clinical Trial Update: Drug Interaction Between Paracetamol and Warfarin [Phase 4]
Phase 4 clinical trial evaluating the interaction between paracetamol and warfarin has completed, in patients with thrombotic conditions.
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: Celect Vena Cava Filter Clinical Trial [NA]
Completed clinical trial for Celect Vena Cava Filter with results posted.
-
FDA approval · 2010-03-26FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
This clinical trial update investigates whether prothrombin fragments 1+2 can prognosticate the incidence of pulmonary embolism, with the st…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [Phase 2, Phase 3]
BMS-562247, studied in patients undergoing elective total knee replacement, completed its Phase 2/3 program for prevention of venous thrombo…
-
FDA approval · 2009-12-23FDA Approved: FRAGMIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Fragmin (dalteparin sodium) submitted by Pfizer Laboratories Div Pfizer Inc. The action indicate…
-
CLINICAL_TRIALS trial_result · 2009-12-10Clinical Trial Update: The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Phase 3]
Phase 3 trial evaluating fondaparinux (GSK576428) for acute pulmonary embolism in Japanese patients has completed. Results were posted in De…
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Epoprostenol in Pulmonary Embolism [Phase 4]
A Phase 4 clinical trial evaluating epoprostenol for acute pulmonary embolism has completed.
-
CLINICAL_TRIALS research · 2009-11-02Clinical Trial Update: Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality
This document reports an update on a clinical trial evaluating whether continuing antiplatelet therapy after spine surgery affects postopera…
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Registry of Hospitalized Patients Treated With Fondaparinux
A registry update describes hospitalized patients treated with fondaparinux for deep vein thrombosis or pulmonary embolism.
-
CLINICAL_TRIALS research · 2009-09-03Clinical Trial Update: VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Update on a pharmacogenomics study examining how VKORC1 and CYP2C9 polymorphisms affect warfarin management across several indications, incl…
-
CLINICAL_TRIALS trial_result · 2009-09-01Clinical Trial Update: Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) [Phase 4]
A Phase 4 clinical trial comparing recombinant streptokinase with urokinase for pulmonary embolism in China has completed.
-
FDA approval · 2009-08-31FDA Approved: HEPARIN SODIUM — Original Application (Hospira, Inc.)
FDA approved an original ANDA for heparin sodium, enabling its generic commercialization by Hospira, Inc.
-
FDA approval · 2009-08-14FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS other · 2009-08-07Clinical Trial Update: Catheter Thrombectomy in Patients With Massive Pulmonary Embolism [Phase 1, Phase 2]
A Phase 1/2 trial of catheter thrombectomy for massive pulmonary embolism has been terminated. The update does not report results.
-
FDA approval · 2009-07-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Heparin Sodium) from Hospira, Inc. The approval updates the product…
-
CLINICAL_TRIALS research · 2009-07-13Clinical Trial Update: Epidemiology of Venous Thromboembolism
This clinical trial update reports the epidemiology of venous thromboembolism and related conditions. The study status is completed.